PiRNA-823 directly recruited DNMT3a and DNMT3b into primary CD138+ MM cells, therefore increasing overall DNA methylation and inhibiting the expression of the tumour suppressor p16INK4A [107]. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.